Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group Women diagnosed with O/PC/FT ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...
JSKN003 has shown a 63% objective response rate and 7.7 months median progression-free survival in PROC patients, with higher efficacy in HER2-positive subgroups. The FDA's fast track designation ...
Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...
1don MSN
I Was 21 When My Doctors Told Me I Had A Year To Live. What Happened Next Left Them Stunned.
"The prognosis was so poor that the hospital called in grief counsellors to speak with my family and help prepare them." ...
Malignant peritoneal mesothelioma is a rare and aggressive cancer that develops in the lining around the abdominal organs. Doctors usually treat it with surgery and chemotherapy. Peritoneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback